Detail The halo effect.   Oleh:  [s.n] Jenis: Article from Bulletin/Magazine Dalam koleksi: Time Magazine vol. 170 no. 13 (Oct. 2007), page 39. Topik: Merck; Charities; Africa Ketersediaan Perpustakaan PKPM Nomor Panggil: T7 Non-tandon: 1 (dapat dipinjam: 0) Tandon: tidak ada     Lihat Detail Induk Isi artikel Drug companies such as Merck have set up programs in Africa to combat HIV/AIDS. Skeptics say it's all just a p.r ploy, but it is the issue of spin even relevant? What the private sector can teach charities about efficiency--and saving lives. Why would any drug company want to do business in Africa? To be a pharmaceutical giant on the continent is to be accused of discriminating against the poor, either by pricing medicine beyond their reach or by ignoring diseases that are endemic is poverty stricken areas. It is also to invite suspicion of using Africans as guinea pigs in unsafe drug trials--such allegations have led to ongoing lawsuits seeking more than $9 billion against Pfizer in Nigeria. Merck's success raises an interesting question: Might business be better at aid than traditional NGOs and charities? Opini Anda Klik untuk menuliskan opini Anda tentang koleksi ini! Kembali

Copyright © 2006, 2007 Unika Atma Jaya, all rights reserved